Atlas Trials

Ofatumumab and Bendamustine for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Clinical trial NCT01010568 · TERMINATED

Trial details

NCT number
NCT01010568
Sponsor
Georgetown University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Start date
2010-04-01
Primary completion
2014-05-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.